Iripin-1

UniProtKB accession:  Q06B75

Grouped By:  Matching UniProtKB accession

UniProtKB description:  Serine protease inhibitor that modulates blood feeding of ticks on vertebrate species (PubMed:36756125). Modestly inhibits human trypsin, plasma kallikrein (KLKB1), matriptase (ST14) and plasmin (PLG) via a classic serpin inhibitory mechanism (PubMed:36756125). Modestly reduces enzymatic activity of human alpha-chymotrypsin, coagulation factor Xa (F10), factor XIIa (F12), cathepsin G (CTSG), tPA/tissue-type plasminogen activator (PLAT) and uPA/urokinase-type plasminogen activator (PLAU) (PubMed:36756125). Probably acts as a substrate rather than an inhibitor for the human neutrophil elastase (ELANE) and thus reduces its enzymatic activity in in vitro assays (PubMed:36756125). Decreases expression of adhesion molecules VCAM1 and CD99 on the surface of human cells (PubMed:36756125). Increases the production of chemokines for neutrophils and monocytes, such as KC/CXCL1, MIP-2/CXCL2 and MIP-1/CCL2, and anti-inflammatory cytokine IL10 in mouse inflammation models (PubMed:36756125). Reduces the recruitment of mouse neutrophils and monocytes to the site of inflammation (PubMed:36756125). Decreases expression of CXCR2 on the surface of mouse neutrophils (PubMed:36756125). Increases expression of integrin ITGAM/ITGB2 on the surface of mouse neutrophils (PubMed:36756125).